Using PI3K inhibitors to increase Par-4, leading to an increase of cl-Par-4, in combination with a chemotherapeutic drug such as cisplatin is an interesting avenue to overcome cancer cells chemoresistance. This evidence concerns the gene PAWR and cancer.